The PIFPAF-PFA Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

November 13, 2023

Primary Completion Date

February 13, 2026

Study Completion Date

February 13, 2028

Conditions
Persistent Atrial Fibrillation
Interventions
PROCEDURE

Pulmonary vein isolation without posterior wall ablation

Pulmonary vein isolation with Pulsed field ablation without left atrial posterior wall ablation. At the end of the procedure, an implantable cardiac monitor will be implanted for the purpose of continuous arrhythmia monitoring

PROCEDURE

Pulmonary vein isolation with posterior wall ablation

Pulmonary vein isolation with Pulsed field ablation with left atrial posterior wall ablation. At the end of the procedure, an implantable cardiac monitor will be implanted for the purpose of continuous arrhythmia monitoring

Trial Locations (6)

1011

University Hospital Lausanne, Lausanne

3010

Inselspital, University Hospital Bern, Bern

Unknown

Cantonal Hospital Baden, Baden

University Hospital Basel, Basel

Cantonal Hospital St. Gallen, Sankt Gallen

University Hospital Zürich, Zurich

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT05986526 - The PIFPAF-PFA Study | Biotech Hunter | Biotech Hunter